Media Pack
News

Current Edition

JCS Volume 15 Issue 4
 
Volume 13 Issue 5

Overview: Pharmacovigilance and Risk Management

Drug development is an expensive, lengthy, and high-risk business taking 1015 years and is associated with a high attrition rate. Approximately only 1 in 10 drugs tha...
18 October 2021 Volume 13 Issue 5 drug development | Market Overview
Continue Reading →
Regional News

Emmes Standardises on Veeva Development Cloud to Streamline Product Development

Global CRO builds technology foundation to drive scalability, efficiency, and compliance PLEASANTON, CA — Sept. 16, 2021 — Veeva Systems (NYSE: VEEV) today announced ...
27 September 2021 Regional News clinical research | CRO
Continue Reading →
Volume 13 Issue 4

Critical Considerations for Clinical Trial Safety Reporting Investments

Naturally, safety event reporting and pharmacovigilance (PV) should be subject to detailed regulatory scrutiny as evidenced by the Food and Drug Administration (FDA) ...
9 August 2021 Volume 13 Issue 4 adverse events | clinical trial
Continue Reading →
 
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte